Skip to content
No results
  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • 2025-12-18

Vaxcyte, Inc. (NASDAQ:PCVX) Expands U.S. Manufacturing And Eyes Near-Term Technical Re-Acceleration

Vaxcyte presents a mixed signal set: strengthening commercial-readiness steps offset by short-term bearish technical momentum, while fundamentals show deep R&D investment and a strong cash buffer consistent with a fair-valued biotech development profile.

  • 2025-12-18

TE Connectivity Ltd. (NYSE:TEL) Projects Near-Term Upside After Strong Q4 Results

TE Connectivity shows operational momentum from record quarterly sales alongside near-term technical pressure that could compress gains. Fundamentals support a value-biased case while short-term indicators warn of a modest pullback risk.
  • 2025-12-18

Monopar Therapeutics Inc. (NASDAQ:MNPR) Secures $100M Financing And Accelerates Clinical Milestones

Monopar enters an active near-term phase after a significant capital raise while clinical and regulatory catalysts approach; balance sheet strength supports further development even as short-term technical momentum softens.
  • 2025-12-18

EZCORP, Inc (NASDAQ:EZPW) Poised To Reprice Upward After Balance-Sheet Cleanup

EZCORP shows a mixed technical posture with short-term pressure while fundamentals and cash reserves support a revaluation opportunity. Operational cash flow, margin expansion, and a WMDST under-valued appraisal frame the stock’s near-term story.
  • 2025-12-18

Spotify Technology S.A. (NYSE:SPOT) Reconfigures Leadership While Near-Term Momentum Remains Contested

Spotify enters a leadership transition as operational metrics show margin expansion but valuation pressures persist; technical indicators point to a contested near-term move around recent support levels.
  • 2025-12-18

Allurion Technologies, Inc. (NYSE:ALUR) Accelerates FDA Pathway; Balance Sheet Stabilization Ahead

Momentum centers on regulatory progress and capital restructuring while operational metrics show material stress; the near-term outlook hinges on FDA milestones and recent financing steps.

  • 2025-12-18

Protagonist Therapeutics, Inc (NASDAQ:PTGX) Accelerates Toward Regulatory Filing And Strategic Interest

Positive long-term trial data and acquisition chatter create near-term headline momentum while technical indicators suggest an elevated probability of a short-lived pullback. Liquidity and cash reserves position the company to advance regulatory filings and program development.
  • 2025-12-18

Lithia Motors, Inc. (NYSE:LAD) Accelerates Luxury Expansion While Near-Term Momentum Builds

Lithia Motors pairs an aggressive luxury-acquisition cadence with constructive technical momentum, while WMDST’s valuation flags the shares as over-valued.
  • 2025-12-17

Sprouts Farmers Market, Inc. (NASDAQ:SFM) Poised To Stabilize After Recent Momentum Shift

Near-term pressure should moderate as profit margins sit above peers and liquidity remains intact. Technical momentum shows conflicting short-term signals that point to consolidation around current levels.
  • 2025-12-17

IES Holdings, Inc. (NASDAQ:IESC) Loses Upward Momentum Ahead Despite Strong Earnings Beat

Strong operating results and a sizable EPS beat contrast with stretched valuation and weakening short-term momentum, suggesting elevated volatility near-term.
Prev
1 … 89 90 91 92 93 94 95 … 138
Next

Introducing The World’s Most Dangerous Swing Trader

2025-09-04
Prev
1 … 84 85 86 87

Trending now

Centene Corporation (NYSE:CNC) Accelerates Cost Cuts While Positioning For Membership Recovery
Magnite, Inc (NASDAQ:MGNI) Posts Bullish Technical Momentum While Valuation Remains Overvalued
Evercore Inc. (NYSE:EVR) Sees Near-Term Pressure Despite Valuation Support
Enerflex Ltd. (NYSE:EFXT) Extends Credit And Signals Near-Term Downside Momentum